K
Karla V. Ballman
Researcher at Cornell University
Publications - 390
Citations - 34158
Karla V. Ballman is an academic researcher from Cornell University. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 78, co-authored 353 publications receiving 29127 citations. Previous affiliations of Karla V. Ballman include University of South Florida & University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
Surgical Treatment of Borderline and Malignant Phyllodes Tumors: The Effect of the Extent of Resection and Tumor Characteristics on Patient Outcome
Edwin O. Onkendi,Rafael E. Jimenez,Grant M. Spears,William S. Harmsen,Karla V. Ballman,Tina J. Hieken +5 more
TL;DR: With long-term follow-up, extent of surgical resection did not affect DFS for patients with borderline and malignant phyllodes tumors, suggesting these high-risk patients may benefit from additional therapeutic strategies.
Journal ArticleDOI
Clinical predictors of exercise capacity 1 year after cardiac transplantation.
Tat Chi Leung,Karla V. Ballman,Thomas G. Allison,J.A. Wagner,Lyle J. Olson,Robert P. Frantz,Brooks S. Edwards,Joseph A. Dearani,Richard C. Daly,Christopher G.A. McGregor,Richard J. Rodeheffer +10 more
TL;DR: In this article, the authors identify clinical features predictive of post-transplant exercise capacity, including age, gender, body mass index, exercise peak heart rate and duration of postoperative intensive care.
Journal ArticleDOI
Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for Limited Brain Metastases: A Secondary Analysis of the North Central Cancer Treatment Group N0574 (Alliance) Randomized Controlled Trial.
Thomas M. Churilla,Karla V. Ballman,Karla V. Ballman,Paul D. Brown,Erin Twohy,Kurt A. Jaeckle,Elana Farace,Jane H. Cerhan,S. Keith Anderson,Xiomara W. Carrero,Yolanda I. Garces,Fred G. Barker,Richard L. Deming,Jesse G. Dixon,Stuart H. Burri,Caroline Chung,Cynthia Ménard,Volker W. Stieber,Bruce E. Pollock,Evanthia Galanis,Jan C. Buckner,Anthony L. Asher +21 more
TL;DR: This study further supports the approach of SRS alone in the majority of patients with limited brain metastases with favorable-prognosis NSCLC patients as well as whole-brain radiation therapy (WBRT) alone.
Journal ArticleDOI
Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naïve, Metastatic, Castration-Resistant Prostate Cancer
Emmanuel S. Antonarakis,Scott T. Tagawa,Giuseppe Galletti,Daniel Worroll,Karla V. Ballman,Marie Vanhuyse,Guru Sonpavde,Scott North,Costantine Albany,Che-Kai Tsao,John Stewart,Atef Zaher,Ted H. Szatrowski,Wei Zhou,Ada Gjyrezi,Shinsuke Tasaki,Luigi Portella,Yang Bai,Timothy B. Lannin,Shalu Suri,Conor N. Gruber,Erica D. Pratt,Brian Kirby,Mario A. Eisenberger,David M. Nanus,Fred Saad,Paraskevi Giannakakou +26 more
TL;DR: The early taxane switch strategy was associated with improved PSA response rates versus TAX327 and taxane-induced shifts in %ARNL may serve as an early biomarker of clinical benefit in patients treated with taxanes.
Journal ArticleDOI
A Phase II Trial Exploring the Success of Cryoablation Therapy in the Treatment of Invasive Breast Carcinoma: Results from ACOSOG (Alliance) Z1072.
Rache M. Simmons,Karla V. Ballman,Charles E. Cox,Ned Carp,Jennifer L. Sabol,Rosa F. Hwang,Deanna J. Attai,Michael S. Sabel,David Nathanson,Andrew S Kenler,Linsey Gold,Cary S. Kaufman,Linda Han,Aaron Bleznak,J. Stanley Smith,Dennis R. Holmes,Bruno D. Fornage,Carisa Le-Petross,Syed A. Hoda,Linda M. McCall,Kelly K. Hunt +20 more
TL;DR: This phase II trial exploring the effectiveness of cryoablation in the treatment of breast cancers showed successful ablation in 66/87 (75.9 %) cancers, and further studies with modifications on the Z1072 protocol could be considered to evaluate the role for cryoABlation as a non-surgical treatment of early-stage breast cancer.